Product ecosystem
MVERSE® is a Russian biotechnology company and technology platform for standardized microbiome analysis. It combines reagent kits, laboratory protocols and software tools for processing metagenomic data.
We have developed an end-to-end technology workflow — from biological sample preparation and sequencing to quality control, analysis and structured reporting.
This enables laboratories and research and medical centers to generate reproducible microbiome data, build a digital biobank and use it as a foundation for evidence-based solutions in personalized nutrition, pharmaceuticals and therapy support.
We turn microbiome science into standard laboratory practice.
FAQ

We value transparency. If you haven't found an answer, please leave a request, and we'll discuss it over a short call.
How is M-Balance different from PCR and culture?
We sequence the full 16S rRNA gene and identify bacteria to the species level. PCR detects predefined markers, while culture depends on growth conditions. M-Balance combines NGS with standardized quality control.
What equipment is required?
What does the platform include, and how much does it cost?
What is the current registration and public health insurance reimbursement status?
How much does one sample cost?
How quickly can we launch the test?
